Zdrowie i gospodarka · 18/11/2020
FDA Requests Public Comment on Proposed Collection of Information for Expedited Programs for Serious Conditions-Drugs and Biologics
The Food and Drug Administration is seeking public input on a proposed collection of information related to expedited programs for serious conditions, including drugs and biologics, in accordance with the Paperwork Reduction Act of 1995.